Anti-PDCD1 Neutralizing Antibody (V3S-0622-YC5183) (CAT#: V3S-0622-YC5183)

Send Inquiry
  • fig1
    Figure 1 ELISA analysis of anti-PD-1 antibody (Cat# V3S-0622-YC5183).
  • fig1
    Figure 2 Western blot analysis of anti-PD-1 antibody (Cat# V3S-0622-YC5183).
  • fig1
    Figure 3 Dot blot analysis of anti-PD-1 antibody (Cat# V3S-0622-YC5183).

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a human monoclonal antibody that reacts with PDCD1. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation.
Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free.
Clonality Monoclonal
Host Species Human
Target Species Human
Isotype IgG

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and/or SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C.

Applications

Application WB; IF; IP; Neut; FuncS; ELISA; FC; ICC
Application Notes The antibody is recommended for detection of PDCD1 by IF, IP, Neut, FuncS, ELISA, FC, ICC assays.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target PDCD1
Alternative Name PD1; PD-1; CD279; SLEB2; hPD-1; hPD-l; hSLE1
Gene ID 5133
UniProt Q15116
Research Area Cell Biology; Immunology

Tested Data

ELISA

Figure 1 ELISA analysis of anti-PD-1 antibody (Cat# V3S-0622-YC5183).

ELISA analysis of anti-PD-1 antibody (Cat# V3S-0622-YC5183) was performed by coating with recombinant human PD-1 protein (His tag). Then blocked with BSA and incubated with anti-PD-1 antibodies. The HRP-conjugated goat anti-human IgG was used as a secondary antibody. Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.

Figure 1 ELISA analysis of anti-PD-1 antibody (Cat# V3S-0622-YC5183).

WB

Figure 2 Western blot analysis of anti-PD-1 antibody (Cat# V3S-0622-YC5183).

Western blot analysis of anti-PD-1 antibody (Cat# V3S-0622-YC5183) was performed by loading human PD-1 protein (His tag) onto a 12% Tris-HCl polyacrylamide gel. proteins were transferred to a NC membrane and blocked with 5% skim milk for at least one hour. Membranes were probed with anti-PD-1 antibodies and HRP goat anti-human IgG was used as a secondary antibody (1/2000).
Lane 1: Reduced antigen (0.1 μg)
Lane 2: Reduced antigen (0.3 μg)
Lane 3: Reduced antigen (0.6 μg)

Figure 2 Western blot analysis of anti-PD-1 antibody (Cat# V3S-0622-YC5183).

DB

Figure 3 Dot blot analysis of anti-PD-1 antibody (Cat# V3S-0622-YC5183).

Dot blot analysis of anti-PD-1 antibody (Cat# V3S-0622-YC5183) was performed by coating with human PD-1 protein (His tag).
The anti-PD-1 antibody incubation concentration: 2 μg/mL.
HRP-conjugated goat anti-human IgG was used as a secondary antibody (1/2000).

Figure 3 Dot blot analysis of anti-PD-1 antibody (Cat# V3S-0622-YC5183).

For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry